CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran
Background and Aims: Fitusiran is an RNA interference therapy that lowers antithrombin (AT) levels, thereby restoring hemostatic balance in patients with hemophilia A or B, regardless of inhibitor status. However, clinical experience with perioperative management of major surgery in patients receiv...
Spremljeno u:
| Format: | Artigo |
|---|---|
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications
2025-10-01
|
| Serija: | Bleeding, Thrombosis and Vascular Biology |
| Teme: | |
| Online pristup: | https://www.btvb.org/btvb/article/view/239 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|